Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.

Grammatikos G, Schoell N, Ferreirós N, Bon D, Herrmann E, Farnik H, Köberle V, Piiper A, Zeuzem S, Kronenberger B, Waidmann O, Pfeilschifter J.

Oncotarget. 2016 Apr 5;7(14):18095-105. doi: 10.18632/oncotarget.7741.

2.

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.

Grammatikos G, Ferreiròs N, Waidmann O, Bon D, Schroeter S, Koch A, Herrmann E, Zeuzem S, Kronenberger B, Pfeilschifter J.

PLoS One. 2015 Sep 18;10(9):e0138130. doi: 10.1371/journal.pone.0138130. eCollection 2015.

3.

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.

Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2015 Jun 29;10(6):e0132119. doi: 10.1371/journal.pone.0132119. eCollection 2015.

4.

The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13.

Aguileta MA, Korac J, Durcan TM, Trempe JF, Haber M, Gehring K, Elsasser S, Waidmann O, Fon EA, Husnjak K.

J Biol Chem. 2015 Mar 20;290(12):7492-505. doi: 10.1074/jbc.M114.614925. Epub 2015 Feb 9.

5.

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S, Ferreirós N, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2014 Jul 25;9(7):e103532. doi: 10.1371/journal.pone.0103532. eCollection 2014.

6.

SEMS vs cSEMS in duodenal and small bowel obstruction: high risk of migration in the covered stent group.

Waidmann O, Trojan J, Friedrich-Rust M, Sarrazin C, Bechstein WO, Ulrich F, Zeuzem S, Albert JG.

World J Gastroenterol. 2013 Oct 7;19(37):6199-206. doi: 10.3748/wjg.v19.i37.6199.

7.

Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers.

Köberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bönig H, Peveling-Oberhag J, Biondi RM, Zeuzem S, Kronenberger B, Waidmann O, Piiper A.

PLoS One. 2013 Sep 20;8(9):e75184. doi: 10.1371/journal.pone.0075184. eCollection 2013.

8.

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.

Bergis D, Kassis V, Ranglack A, Koeberle V, Piiper A, Kronenberger B, Zeuzem S, Waidmann O, Radeke HH.

Transl Oncol. 2013 Jun 1;6(3):311-8. Print 2013 Jun.

9.

Serum microRNA-122 predicts survival in patients with liver cirrhosis.

Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B.

PLoS One. 2012;7(9):e45652. doi: 10.1371/journal.pone.0045652. Epub 2012 Sep 28.

10.

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.

Kronenberger B, Rudloff I, Bachmann M, Brunner F, Kapper L, Filmann N, Waidmann O, Herrmann E, Pfeilschifter J, Zeuzem S, Piiper A, Mühl H.

BMC Med. 2012 Sep 11;10:102. doi: 10.1186/1741-7015-10-102.

11.

Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.

Haupenthal J, Bihrer V, Korkusuz H, Kollmar O, Schmithals C, Kriener S, Engels K, Pleli T, Benz A, Canamero M, Longerich T, Kronenberger B, Richter S, Waidmann O, Vogl TJ, Zeuzem S, Piiper A.

Neoplasia. 2012 May;14(5):410-9.

12.

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.

Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, Welker M, Shi Y, Peveling-Oberhag J, Polta A, von Wagner M, Radeke HH, Sarrazin C, Trojan J, Zeuzem S, Kronenberger B, Piiper A.

PLoS One. 2011;6(10):e26971. doi: 10.1371/journal.pone.0026971. Epub 2011 Oct 31.

13.

Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.

Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dötsch V, Bumann D, Dikic I.

Science. 2011 Jul 8;333(6039):228-33. doi: 10.1126/science.1205405. Epub 2011 May 26.

14.

Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products.

Waidmann O, Pleli T, Dvorak K, Baehr C, Mondorf U, Plotz G, Biondi RM, Zeuzem S, Piiper A.

J Biol Chem. 2009 Nov 20;284(47):32256-63. doi: 10.1074/jbc.M109.056622. Epub 2009 Sep 29.

15.

The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice.

Lappe-Siefke C, Loebrich S, Hevers W, Waidmann OB, Schweizer M, Fehr S, Fritschy JM, Dikic I, Eilers J, Wilson SM, Kneussel M.

PLoS Genet. 2009 Sep;5(9):e1000631. doi: 10.1371/journal.pgen.1000631. Epub 2009 Sep 4.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk